Page last updated: 2024-08-24

3-iodobenzylguanidine and Thyroid Diseases

3-iodobenzylguanidine has been researched along with Thyroid Diseases in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (36.36)	18.2507
2000's	3 (27.27)	29.6817
2010's	3 (27.27)	24.3611
2020's	1 (9.09)	2.80

Authors

Authors	Studies
Garrido Magaña, E; Nishimura Meguro, E; Rivera Hernández, AJ; Silva Estrada, JA; Zurita Cruz, JN	1
Kraal, KC; Tytgat, GA; van Dalen, EC; Van Eck-Smit, BL	1
Ballinger, JR	1
Clement, SC; Kremer, LC; Tytgat, GA; van Eck-Smit, BL; van Santen, HM; van Trotsenburg, AS	1
de Kraker, J; de Vijlder, JJ; van Eck, BL; van Santen, HM; Vulsma, T	2
de Kraker, J; van Santen, HM; Vulsma, T	1
Boscaino, A; Brunetti, A; Klain, M; Lastoria, S; Lupoli, G; Maurea, S; Salvatore, M	1
Oyamada, H	1
Clarke, SE	1
Konishi, J	1

Reviews

3 review(s) available for 3-iodobenzylguanidine and Thyroid Diseases

Article	Year
Iodine-131-meta-iodobenzylguanidine therapy for patients with newly diagnosed high-risk neuroblastoma. The Cochrane database of systematic reviews, 2017, Apr-21, Volume: 4 Topics: 3-Iodobenzylguanidine; Adolescent; Antineoplastic Agents; Bone Marrow; Child; Child, Preschool; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Infant; Neuroblastoma; Observational Studies as Topic; Radiopharmaceuticals; Thyroid Diseases; Topotecan	2017
Theranostic radiopharmaceuticals: established agents in current use. The British journal of radiology, 2018, Volume: 91, Issue:1091 Topics: 3-Iodobenzylguanidine; Antigens, CD20; Bone Neoplasms; Dipeptides; Diphosphonates; Drug Approval; Forecasting; Heterocyclic Compounds, 1-Ring; Hodgkin Disease; Humans; Iodine Radioisotopes; Lutetium; Octreotide; Organometallic Compounds; Prostate-Specific Antigen; Radiopharmaceuticals; Somatostatin; Theranostic Nanomedicine; Thyroid Diseases	2018
Radionuclide therapy of the thyroid. European journal of nuclear medicine, 1991, Volume: 18, Issue:12 Topics: 3-Iodobenzylguanidine; Humans; Iodine Radioisotopes; Iodobenzenes; Thyroid Diseases; Thyroid Neoplasms	1991

Other Studies

8 other study(ies) available for 3-iodobenzylguanidine and Thyroid Diseases

Article	Year
[Thyroid dysfunction due to 131I-metaiodobenzylguanidine in patients with neuroblastoma]. Revista chilena de pediatria, 2020, Volume: 91, Issue:3 Topics: 3-Iodobenzylguanidine; Child; Child, Preschool; Cross-Sectional Studies; Female; Humans; Hypothyroidism; Infant; Iodine Radioisotopes; Male; Neuroblastoma; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Thyroid Diseases	2020
Long-term follow-up of the thyroid gland after treatment with 131I-Metaiodobenzylguanidine in children with neuroblastoma: importance of continuous surveillance. Pediatric blood & cancer, 2013, Volume: 60, Issue:11 Topics: 3-Iodobenzylguanidine; Adolescent; Child; Child, Preschool; Female; Humans; Infant; Iodine Radioisotopes; Male; Neuroblastoma; Potassium Iodide; Retrospective Studies; Thyroid Diseases; Thyroid Gland; Time	2013
Improved radiation protection of the thyroid gland with thyroxine, methimazole, and potassium iodide during diagnostic and therapeutic use of radiolabeled metaiodobenzylguanidine in children with neuroblastoma. Cancer, 2003, Jul-15, Volume: 98, Issue:2 Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Child; Child, Preschool; Female; Humans; Infant; Male; Methimazole; Neuroblastoma; Potassium Iodide; Radiation-Protective Agents; Thyroid Diseases; Thyroid Function Tests; Thyroxine; Treatment Outcome	2003
Endocrine late effects from multi-modality treatment of neuroblastoma. European journal of cancer (Oxford, England : 1990), 2005, Volume: 41, Issue:12 Topics: 3-Iodobenzylguanidine; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Endocrine System Diseases; Female; Growth Disorders; Humans; Hypogonadism; Infant; Iodine Radioisotopes; Male; Neuroblastoma; Radiopharmaceuticals; Survivors; Thyroid Diseases; Thyrotropin	2005
Diagnostic evaluation of thyroid involvement by histiocytosis X. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1994, Volume: 35, Issue:2 Topics: 3-Iodobenzylguanidine; Contrast Media; Female; Histiocytosis, Langerhans-Cell; Humans; Iodine Radioisotopes; Iodobenzenes; Middle Aged; Organotechnetium Compounds; Radionuclide Imaging; Succimer; Technetium Tc 99m Dimercaptosuccinic Acid; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Thyroid Diseases; Ultrasonography	1994
[Present status of unsealed radioisotope therapy in Japan based on the nation-wide questionnaire]. Kaku igaku. The Japanese journal of nuclear medicine, 1999, Volume: 36, Issue:2 Topics: 3-Iodobenzylguanidine; Humans; Hyperthyroidism; Iodine Radioisotopes; Japan; Surveys and Questionnaires; Thyroid Diseases; Thyroid Neoplasms	1999
High incidence of thyroid dysfunction despite prophylaxis with potassium iodide during (131)I-meta-iodobenzylguanidine treatment in children with neuroblastoma. Cancer, 2002, Apr-01, Volume: 94, Issue:7 Topics: 3-Iodobenzylguanidine; Adolescent; Brain Neoplasms; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Incidence; Infant; Infant, Newborn; Male; Neoplasm Staging; Neuroblastoma; Potassium Iodide; Premedication; Radiation Injuries; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Thyroid Diseases; Thyroid Gland; Thyrotropin; Thyroxine	2002
[Effective image diagnosis of thyroid diseases]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1990, Jul-10, Volume: 79, Issue:7 Topics: 3-Iodobenzylguanidine; Humans; Iodine Radioisotopes; Iodobenzenes; Magnetic Resonance Imaging; Radionuclide Imaging; Sodium Pertechnetate Tc 99m; Thyroid Diseases; Thyroid Gland; Ultrasonography	1990